Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP6V0E1P2 is a human processed pseudogene located on chromosome 3[9], derived as a retrocopy of the ATP6V0E1 gene[7][9]. ATP6V0E1 itself encodes a V0 subunit e1 of the vacuolar ATPase (V-ATPase), an enzyme involved in proton transport across lysosomal and vacuolar membranes. However, ATP6V0E1P2 is a non-functional genomic element and does not produce a protein. While some pseudogenes have been shown to participate in gene regulation via their RNA transcripts, no regulatory or disease-related roles for ATP6V0E1P2 have been described in the literature or genetic databases. As such, it is not considered a molecular target for therapeutic intervention[1][3][4][5][7][8][9].\n\nATP6V0E1P2 is a pseudogene (non-coding, retrocopy) of ATP6V0E1, not a canonical therapeutic target, not associated with any known drug interactions, disease roles, or safety issues, and lacks an established biological function[1][3][4][5][7][8][9].
None. There are no mechanisms of action described for ATP6V0E1P2, as it is not a drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATPase H+ transporting V0 subunit e1 pseudogene 2 (ATP6V0E1P2).